Inici › Anèmia falciforme › Illinois › Chicago
Assaigs clínics de Anèmia falciforme a Chicago, IL
18 estudis de Anèmia falciforme busquen participants en centres de Chicago i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease
ReclutantFase 1
- University of Illinois at Chicago College of Medicine, Chicago
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
ReclutantFase 3
- Uni of Illinois Hospital and HSC, Chicago
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
ReclutantFase 1
- University of Illinois Hospital and Health Sciences System, Chicago
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
ReclutantFase 3
- Univer Of Illinois at Chicago, Chicago
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
ReclutantFase 3
- Childrens Hospital of Chicago, Chicago
- Univer Of Illinois at Chicago, Chicago
Tocilizumab for Acute Chest Syndrome
ReclutantFase 2
- University of Chicago, Chicago
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
ReclutantFase 1/2Voluntaris sans benvinguts
- Local Institution - 0034, Chicago
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
ReclutantFase 2/3
- University of Illinois at Chicago Clinical Research Center, Chicago
- University of Illinois Hospital and Health Sciences System - Investigational Drug Services (IDS), Chicago
- University of Illinois Hospital and Health Sciences System, Chicago
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
ReclutantEstudi observacional
- Rush University Medical Center, Chicago
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
ReclutantFase 2
- University of Illinois at Chicago, Chicago
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
ReclutantFase 3
- University of Illinois-Chicago - College of Medicine- Site Number : 8400054, Chicago
Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease
ReclutantFase 2
- University of Illinois at Chicago, Chicago
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
ReclutantEstudi observacional
- Comer Children's Hospital (MRD-HCT), Chicago
Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
ReclutantFase 2
- University of Illinois Chicago, Sickle Cell Center, Chicago
Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
Reclutant
- University of Illinois at Chicago, Chicago
Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
ReclutantFase 2
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
Reclutant
- Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
ReclutantEstudi observacional
- University of Illinois, Chicago
Assaigs de Anèmia falciforme en altres ciutats
- Atlanta, GA22 estudis
- Washington, DC20 estudis
- Memphis, TN18 estudis
- Philadelphia, PA15 estudis
- Birmingham, AL14 estudis
- New York City, NY13 estudis
- St. Louis, MO12 estudis
- Durham, NC10 estudis
- Cincinnati, OH10 estudis
- Houston, TX10 estudis
- Boston, MA10 estudis
- Pittsburgh, PA9 estudis
Altres estudis a Chicago
- Càncer de pulmó de cèl·lules no petites61 estudis
- Càncer de mama58 estudis
- Càncer (tots els tipus)51 estudis
- Càncer metastàtic45 estudis
- Càncer de pròstata45 estudis
- Obesitat41 estudis
- Càncer de pulmó41 estudis
- Càncer d'ovari36 estudis
- Ictus34 estudis
- Càncer colorrectal33 estudis
- Insuficiència cardíaca31 estudis
- Sobrepès28 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.